about
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamicsDrugging MYCN through an allosteric transition in Aurora kinase ACombined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable diseaseMedulloblastoma stem cells: Promising targets in medulloblastoma therapyDevelopment and cancer of the cerebellumInhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsIn vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model.The prenatal origins of cancerInhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.Investigation of brain tissue infiltration by medulloblastoma cells in an ex vivo modelOrthotopic models of pediatric brain tumors in zebrafishAlterations in the nuclear proteome of HIV-1 infected T-cells.Deregulated proliferation and differentiation in brain tumors.Molecular subgroups of medulloblastoma.Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastomaGene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesisSerpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modellingAn animal model of MYC-driven medulloblastomaClonal selection drives genetic divergence of metastatic medulloblastoma.Myc proteins in brain tumor development and maintenance.MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-propertiesDistinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.Novel cell lines established from pediatric brain tumors.BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.An interferon response gene expression signature is activated in a subset of medulloblastomasComplex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.Illuminating cancer systems with genetically engineered mouse models and coupled luciferase reporters in vivoNeural stem cell-encoded temporal patterning delineates an early window of malignant susceptibility in Drosophila.The role of stem cells and progenitors in the genesis of medulloblastomaRole of MYC in Medulloblastoma.Expression and function of the testis-predominant protein LYAR in mice.Medulloblastomics: the end of the beginning.Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer.MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.Molecular diagnostics of CNS embryonal tumors.Mouse models of medulloblastoma.Review: personalized mice: modelling the molecular heterogeneity of medulloblastoma.
P2860
Q24294672-5BBC2E46-A026-4B35-8EF3-E529F3944DC7Q24303381-3619EB5B-773F-40E7-896D-72B1B3531B72Q24310764-EEF88CBF-1C17-4246-9147-FE8B7F6A4777Q26750427-725FEEE4-19DD-4F15-993B-0E30BFE0D88BQ28305235-35ADC125-E011-4D2C-8B84-F11DE7E2DE95Q28817295-4F09DCF1-E342-448A-B6F0-4C1A12E97B0BQ30618694-33E14261-F2BB-4978-B66A-11A77A0CE138Q33697463-61398A28-5FE0-44BF-8A93-E8326761824DQ33756997-B9D9C5C0-D2C4-4390-B1C5-064F496E33E7Q33903199-3AA32906-0AE3-46EF-8583-7AED374CEF21Q34381550-A878FEA5-5C2B-4515-BD5F-1E9E6E67227BQ34620114-D257A0FE-C2E6-4101-855A-E4D0BC19EF66Q34859989-46BC67A7-C1C0-4A7C-BE90-366431D3CCAEQ35101347-0431E61A-5736-43D4-B21D-5CD7B7BE830EQ35192672-D1439D17-2BCF-413B-8A80-4B700AF10719Q35440212-94AD02CD-40D0-45A9-8ABE-70F909C6843FQ35611341-5927B416-20AC-4471-B2B5-7E348E2E453AQ35742331-2D7C2E19-8D40-4D77-9FFE-D05E7B92EAFAQ35774418-540D7FD0-0F0D-49A1-B93D-B7590B591FEDQ35784926-9F5127C2-215C-488E-9608-7AD4F7EF8E0EQ35920494-B00AAE07-7DAB-4C15-B72E-256E53B9F94FQ35925281-0C5BC5BE-52E8-42B3-84FA-F21F4C90059EQ35989886-8DC3F9EE-48AD-4162-961A-578B01707E1DQ36047046-7A975236-A878-408A-8107-9EEBC43B85C1Q36054158-FF9394AB-8D99-4770-9443-5B52DFE21940Q36199866-E54E6B30-E800-47D1-B077-B512C53A71BEQ36280796-DE293927-F651-41BC-967A-DE89087A3A1BQ36451030-3188A665-9698-4AAE-BC77-10531241F9F9Q36920226-95B7B340-072D-4680-97B0-E7F76896DACAQ37003765-28CE5FC6-9EAA-456A-8706-ADD3C9ECE787Q37033873-D71182C4-E356-46B4-9D08-C2B8067211C7Q37256443-0A565809-B513-470D-8234-FCB198C4340FQ37462111-36109C22-FF1B-4D52-9F43-26C7419964C9Q37469904-56B8B579-E04D-474B-A975-5B600F337180Q37600904-D807315B-1042-4AD4-8E30-CA373C3B1132Q37649646-61ED3D53-52DE-43AE-B014-344A70F4F5BBQ37672145-5B6603C5-202C-47F8-B054-27DE41AAFF42Q37794829-B6F2A694-E519-4D9A-83B5-974E58E9554AQ37896219-0C314990-D4B3-4DEC-8C86-5DC6643E2B87Q37954412-B7C30026-2F0E-40DF-B6A4-961C885EBF6F
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pleiotropic role for MYCN in medulloblastoma.
@en
type
label
Pleiotropic role for MYCN in medulloblastoma.
@en
prefLabel
Pleiotropic role for MYCN in medulloblastoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Pleiotropic role for MYCN in medulloblastoma.
@en
P2093
C David James
Christopher S Hackett
David D Goldenberg
Heather C Flynn Gilmer
Jasmine Lau
Joanna J Phillips
Kim Nguyen
Kohichi Tanaka
Mai Nagaoka
Michael D Taylor
P2860
P304
P356
10.1101/GAD.1907510
P577
2010-05-01T00:00:00Z